5Chamfly V. French evaluation of conditions for the systematic implementation of leucocyte removal in labile blood products (LBP).Transfus Sci, 1998; 19:333 - 342
6Masse M. Universal leukoreduction of cellular and plasma components: process control and performance of the leukoreduction process. Transfus Clin Biol, 2001; 8: 297 - 302
7Yaprak I, Yercen N, Aksit S, et al. A comparison of different filters for white cell reduction. Turk J Pediatr, 1998; 40:89 - 95
8Racz Z. Characteristics of lymphocytes and granulocytes removed from whole blood by buffy coat depletion. Comparison of an automated bottom-and-Top processing system and the manual technique.Arch Med Res, 2000; 31:53 - 57
9Royer D, Pommier P, Polidori Y, et al. The platelet/leukocyte ratio in red blood cell concentrates is an essential indicator of leukocyte removal filter efficiency which limits their use. Transfus Clin Biol,2000; 7: 70 - 75
10Hammer JH, Mynster T, Reimert CM, et al. Reduction of bioactive substances in stored donor blood: prestorage versus bedside leucofiltration. Eur J Haematol, 1999; 63:29 - 34
3British Committee for Standards in Haematology,Blood Transfusion Task Force.Guidelines for the use of fresh frozen plasma,cryop recip itate and cryosupernatant[J].Br Soci Haematol,2004,126(1):11-28.
4MarconiM.Italian guidelines for the appropriate use of plasma[J].Tumori,2001,87(2):14-16.
5Luk C,Eckert KM,Barr RM,et al.Prospective audit of the use of fresh frozen plasma,based on Canadian Medical Association transfusion guidelines[J].CMAJ,2002,166(12):1539-1540.
6Schofield WN,Rubin GL,Dean MG.App rop riateness of platelet,fresh frozen plasma and cryp recipitate transfusion in New SouthWales public hospital[J].Medi J Am,2003,178(3):117-120.
7Kushner I.Regulation of the acute phase resone by cytokines[J].Perspect Biol Med,1993,36:611.
